All articles by Anthony King – Page 15
-
BusinessPfizer and Allergan agree mega-merger
$160 billion deal allows Pfizer to escape US tax system by re-homing in Ireland
-
NewsPoor management of antibiotics squandering life-saving drugs
Internet and over-the-counter sales along with counterfeit drugs are driving a worldwide rise in antimicrobial resistance
-
NewsEurope picks its panel of seven scientific advisers
The commission’s new advisory support team will be backed up by more money and resources than the chief scientific adviser post it replaces
-
NewsPoor diagnostics hinder battle against antibiotic resistance
Healthcare workers’ tools to diagnose infections remain stuck in the past
-
ResearchWildflowers serve as reservoir for controversial pesticides
Crop pollen has levels of neonicotinoid insecticides 10 times lower than native species
-
NewsChemistry at heart of VW emissions cheating
Car firm dodged nitrogen oxide pollution limits using software that detected testing
-
ResearchClick chemistry creates precision polymers
New synthesis technique allows the length and stereochemistry of artificial polymers to be controlled
-
BusinessGreek crisis puts pressure on pharmaceuticals
Public spending cuts and capital restrictions on banks have exacerbated drug supply problems in Greece
-
NewsMetrics have their place but peer review remains king
Review calls for responsible use of metrics in UK research
-
NewsEU science chief sets out proposals to boost innovation and research integrity
Carlos Moedas wants to set up an Innovation Council and an initiative to tackle misconduct in Europe
-
FeaturePharma goes hi-tech
Technology and telecommunications have the potential to revolutionise healthcare, as Anthony King reports
-
NewsRoadmap to reward pharma for creating new antibiotics unveiled
Report recommends large up-front payments and an innovation fund for blue skies research to tackle microbial resistance
-
BusinessMerger creates biggest supplier of unlicensed drugs
Clinigen will buy Idis to consolidate different routes by which doctors can access medicines that are unavailable locally
-
ResearchChemicals formed on meteorites may have started life on Earth
Simple chemical turned into DNA bases and other precursors to life on simulated meteorite surface
-
NewsReview plots path to face down antimicrobial resistance deaths
Billion dollar innovation fund called for to kick-start antimicrobial drug research in the UK
-
NewsAntimicrobial resistance will kill 300 million by 2050 without action
UK report says resistance will cost global economy $100 trillion
-
ResearchSmart skin for prosthetic limbs senses heat and touch
Ultra-thin plastic skin can bend and flex without affecting the skin’s ability to detect stimuli
-
BusinessCystic Fibrosis Foundation sells drug royalty rights for $3.3bn
‘Venture philanthropy’ model pays off with massive cash injection for charity
-
ResearchHomes can wrap up warm with super-insulating foam
Graphene oxide, clay and cellulose nanofibres turned into a cheap, fireproof insulator that performs better than conventional materials
-
BusinessIneos bets big on shale
UK profit-sharing plan and transatlantic ethane shipping contracts show company’s commitment to a fracking future